Megalis: Restore Confidence with Effective Erectile Dysfunction Treatment

Megalis

Megalis

Megalis is often used to treat impotence or erectile dysfunction (ED) in men. Megalis 20 mg is also used to treat pulmonary arterial hypertension and benign prostatic hyperplasia (BPH). While Tadalafil is the main active ingredient, this medicine contains other inactive ingredients such as lactose, iron oxide, magnesium stearate, microcrystalline cellulose, and others.
Product dosage: 20 mg
Package (num)Per pillPriceBuy
60
0.92 $ Best per pill
54.99 $ (0%)🛒 Add to cart
Synonyms

Megalis is a trusted prescription medication containing Tadalafil, a potent PDE5 inhibitor clinically proven to manage erectile dysfunction. It works by increasing blood flow to the penis, facilitating firm and sustainable erections when sexually stimulated. This treatment offers a reliable solution for men seeking to improve their sexual health and intimate relationships, supported by extensive research and a well-understood safety profile. Consult your healthcare provider to determine if Megalis is appropriate for your specific condition.

Features

  • Active ingredient: Tadalafil 10 mg or 20 mg
  • Belongs to the phosphodiesterase type 5 (PDE5) inhibitor class
  • Onset of action within 30 minutes to 1 hour
  • Duration of effect up to 36 hours
  • Available in tablet form for oral administration
  • Requires sexual stimulation for efficacy

Benefits

  • Enables achieving and maintaining erections sufficient for sexual activity
  • Provides a prolonged window of opportunity, reducing time-related anxiety
  • Supports improved sexual confidence and relationship satisfaction
  • Non-daily dosing option available for spontaneous intimacy
  • Clinically demonstrated efficacy in diverse patient populations, including those with diabetes
  • May alleviate performance-related stress through reliable pharmacological action

Common use

Megalis is primarily prescribed for the treatment of erectile dysfunction (ED) in adult males. It is also approved for the treatment of benign prostatic hyperplasia (BPH) and may be used off-label or in combination for pulmonary arterial hypertension under strict medical supervision. Patients typically use it on an as-needed basis prior to anticipated sexual activity, though daily low-dose regimens exist for continuous therapeutic effect.

Dosage and direction

The recommended starting dose for erectile dysfunction is 10 mg taken orally at least 30 minutes before sexual activity. Based on efficacy and tolerability, the dose may be increased to 20 mg or decreased to 5 mg. For daily use, a 2.5 mg or 5 mg dose is taken once daily without regard to timing of sexual activity. Do not exceed one dose in a 24-hour period. Take with or without food; avoid high-fat meals which may delay onset. Swallow the tablet whole with a glass of water.

Precautions

  • Not intended for use by women, children, or adolescents under 18 years
  • Use caution in patients with cardiovascular disease; sexual activity poses potential cardiac risk
  • Avoid concurrent use with other erectile dysfunction treatments
  • Priapism (prolonged erection >4 hours) requires immediate medical attention to prevent tissue damage
  • May cause hypotension; rise slowly from sitting/lying position to avoid dizziness
  • Use protective measures against sexually transmitted diseases as Megalis does not provide protection

Contraindications

  • Hypersensitivity to Tadalafil or any component of the formulation
  • Concurrent use of organic nitrates or nitric oxide donors in any form
  • Patients with severe hepatic impairment (Child-Pugh Class C)
  • Unstable angina, recent myocardial infarction, or life-threatening arrhythmias
  • History of non-arteritic anterior ischemic optic neuropathy (NAION)
  • Severe hypotension or uncontrolled hypertension

Possible side effects

Common side effects (>1%) include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and limb pain. These are generally mild to moderate and transient. Less frequently reported effects include dizziness, visual disturbances, gastroesophageal reflux, and palpitations. Rare but serious adverse events include sudden hearing loss, priapism, and cardiovascular events. Report any persistent or severe symptoms to your healthcare provider promptly.

Drug interaction

Tadalafil is primarily metabolized by CYP3A4. Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) necessitates dose reduction. Avoid combining with alpha-blockers due to additive hypotensive effects. Concurrent use with nitrates is absolutely contraindicated. Use caution with antihypertensives, alcohol, and other vasodilators. Inform your physician of all medications, including over-the-counter drugs and herbal supplements.

Missed dose

For as-needed dosing: take when remembered if sufficient time remains before sexual activity. Do not double the dose. For daily dosing: take as soon as remembered unless it is nearly time for the next dose, in which case skip the missed dose and resume the regular schedule.

Overdose

Symptoms may include severe headache, dizziness, fainting, prolonged erection, and pronounced hypotension. In case of suspected overdose, seek immediate medical attention. Supportive measures include maintaining supine position and adequate hydration. Hemodialysis is not expected to significantly enhance elimination. Priapism requires urgent urological intervention.

Storage

Store at room temperature (15–30°C) in the original container, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused medication properly through take-back programs; do not flush.

Disclaimer

This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized guidance. Do not initiate, adjust, or discontinue medication without medical supervision. Individual results may vary based on health status and adherence to prescribed therapy.

Reviews

Clinical studies demonstrate Megalis (Tadalafil) significantly improves erectile function scores versus placebo. In integrated analyses, 81% of attempts at sexual intercourse were successful with Tadalafil 20 mg compared to 52% with placebo. Patient-reported outcomes indicate enhanced confidence, satisfaction, and overall sexual experience. Long-term data support maintained efficacy and safety with appropriate use under medical guidance.